IBRX insider transaction filings
ImmunityBio, Inc. — 42 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-07-06. Screen IBRX transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-06 | 4 | Selecky Christobel — Director | Option exercise (M): 35,064 @ $2.98 · Option exercise (M): 124,414 @ $2.99 · Sale (S): 159,478 @ $9.02 · Option exercise (M): 35,064 (derivative) @ $0 · Option exercise (M): 124,414 (derivative) @ $0 | EDGAR |
| 2026-07-06 | 4 | Cohen Cheryl — Director | Option exercise (M): 55,979 @ $2.98 · Sale (S): 131,210 @ $9.50 · Option exercise (M): 55,979 (derivative) @ $0 | EDGAR |
| 2026-07-01 | 4 | Selecky Christobel — Director | Option exercise (M): 32,173 @ $2.98 · Option exercise (M): 33,549 @ $2.99 · Option exercise (M): 30,000 @ $2.84 · Sale (S): 95,722 @ $9.01 · Option exercise (M): 700 @ $2.98 · Option exercise (M): 300 @ $2.99 · +6 more | EDGAR |
| 2026-06-26 | 4 | Simon Barry J. — Director | Sale (S): 25,000 @ $7.88 | EDGAR |
| 2026-06-10 | 4 | Selecky Christobel — Director | Grant/award (A): 65,600 (derivative) @ $0 | EDGAR |
| 2026-06-10 | 4 | MAXWELL LINDA — Director | Grant/award (A): 65,600 (derivative) @ $0 | EDGAR |
| 2026-06-10 | 4 | Cohen Cheryl — Director | Grant/award (A): 65,600 (derivative) @ $0 | EDGAR |
| 2026-06-10 | 4 | BLASZYK MICHAEL D — Director | Grant/award (A): 65,600 (derivative) @ $0 | EDGAR |
| 2026-06-10 | 4 | Wendel Bruce — Director | Grant/award (A): 65,600 (derivative) @ $0 | EDGAR |
| 2026-06-10 | 4 | Clark Wesley — Director | Grant/award (A): 65,600 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | Simon Barry J. — Director | Sale (S): 23,033 @ $7.18 | EDGAR |
| 2026-04-02 | 4 | SOON-SHIONG PATRICK — See remarks, Director, 10% owner CALIFORNIA CAPITAL EQUITY, LLC — 10% owner Cambridge Equities, LP — 10% owner MP 13 Ventures, LLC — 10% owner Nant Capital, LLC — 10% owner | Conversion (C): 4,606,596 @ $5.43 · Conversion (C) @ $0 | EDGAR |
| 2026-02-26 | 4 | Simon Barry J. — Director | Sale (S): 75,000 @ $12.01 | EDGAR |
| 2026-02-24 | 4 | Selecky Christobel — Director | Option exercise (M): 25,000 @ $2.98 · Sale (S): 25,000 @ $10 · Option exercise (M): 25,000 (derivative) @ $0 | EDGAR |
| 2026-02-24 | 4 | Sachs David C. — Chief Financial Officer | Option exercise (M): 40,650 @ $0 · Tax withholding (F): 20,682 @ $8.70 · Option exercise (M): 40,650 (derivative) @ $0 | EDGAR |
| 2026-02-24 | 4 | Adcock Richard — CEO & President, Director | Option exercise (M): 152,439 @ $0 · Tax withholding (F): 77,560 @ $8.70 · Option exercise (M): 152,439 (derivative) @ $0 | EDGAR |
| 2026-02-24 | 4 | Simon Barry J. — Director | Sale (S): 10,000 @ $9.25 · Option exercise (M): 15,243 @ $0 · Tax withholding (F): 6,026 @ $8.70 · Sale (S): 165,000 @ $10.25 · Option exercise (M): 15,243 (derivative) @ $0 | EDGAR |
| 2026-02-24 | 4 | LAUER REGAN J — Chief Accounting Officer | Option exercise (M): 4,065 @ $0 · Tax withholding (F): 1,673 @ $8.70 · Option exercise (M): 4,065 (derivative) @ $0 | EDGAR |
| 2026-02-24 | 4 | SOON-SHIONG PATRICK — See remarks, Director, 10% owner CALIFORNIA CAPITAL EQUITY, LLC — 10% owner Cambridge Equities, LP — 10% owner MP 13 Ventures, LLC — 10% owner Nant Capital, LLC — 10% owner | Option exercise (M): 114,329 @ $0 · Tax withholding (F): 58,170 @ $8.70 · Option exercise (M): 114,329 (derivative) @ $0 | EDGAR |
| 2026-02-12 | 4 | Sachs David C. — Chief Financial Officer | Option exercise (M): 82,236 @ $0 · Tax withholding (F): 42,643 @ $6.93 · Option exercise (M): 82,236 (derivative) @ $0 | EDGAR |
| 2026-02-12 | 4 | Adcock Richard — CEO & President, Director | Option exercise (M): 274,122 @ $0 · Tax withholding (F): 140,048 @ $6.93 · Option exercise (M): 274,122 (derivative) @ $0 | EDGAR |
| 2026-02-12 | 4 | LAUER REGAN J — Chief Accounting Officer | Option exercise (M): 5,482 @ $0 · Tax withholding (F): 2,257 @ $6.93 · Option exercise (M): 5,482 (derivative) @ $0 | EDGAR |
| 2026-02-12 | 4 | SOON-SHIONG PATRICK — See remarks, Director, 10% owner CALIFORNIA CAPITAL EQUITY, LLC — 10% owner Cambridge Equities, LP — 10% owner MP 13 Ventures, LLC — 10% owner Nant Capital, LLC — 10% owner | Option exercise (M): 274,122 @ $0 · Tax withholding (F): 118,560 @ $6.93 · Option exercise (M): 274,122 (derivative) @ $0 | EDGAR |
| 2026-01-21 | 4 | Selecky Christobel — Director | Option exercise (M): 50,000 @ $2.98 · Sale (S): 50,000 @ $5 · Option exercise (M): 25,000 @ $2.98 · Sale (S): 25,000 @ $7.51 · Option exercise (M): 50,000 (derivative) @ $0 · Option exercise (M): 25,000 (derivative) @ $0 | EDGAR |
| 2026-01-21 | 4 | Simon Barry J. — Director | Sale (S): 76,967 @ $6.54 · Sale (S): 75,000 @ $7.88 | EDGAR |
| 2026-01-05 | 4 | Sachs David C. — Chief Financial Officer | Option exercise (M): 30,397 @ $0 · Tax withholding (F): 15,435 @ $1.98 · Option exercise (M): 30,397 (derivative) @ $0 | EDGAR |
| 2026-01-05 | 4 | Adcock Richard — CEO & President, Director | Option exercise (M): 34,483 @ $0 · Tax withholding (F): 17,510 @ $1.98 · Option exercise (M): 34,483 (derivative) @ $0 | EDGAR |
| 2025-12-16 | 4 | Wendel Bruce — Director | Grant/award (A): 146,020 (derivative) @ $0 | EDGAR |
| 2025-06-20 | 4 | Selecky Christobel — Director | Grant/award (A): 162,786 (derivative) @ $0 | EDGAR |
| 2025-06-20 | 4 | Cohen Cheryl — Director | Grant/award (A): 162,786 (derivative) @ $0 | EDGAR |
| 2025-06-20 | 4 | BLASZYK MICHAEL D — Director | Grant/award (A): 162,786 (derivative) @ $0 | EDGAR |
| 2025-06-20 | 4 | MAXWELL LINDA — Director | Grant/award (A): 162,786 (derivative) @ $0 | EDGAR |
| 2025-06-20 | 4 | Clark Wesley — Director | Grant/award (A): 162,786 (derivative) @ $0 | EDGAR |
| 2025-02-25 | 4 | Sachs David C. — Chief Financial Officer | Option exercise (M): 40,650 @ $0 · Tax withholding (F): 15,860 @ $3.42 · Option exercise (M): 40,650 (derivative) @ $0 | EDGAR |
| 2025-02-25 | 4 | Adcock Richard — CEO & President, Director | Option exercise (M): 152,439 @ $0 · Tax withholding (F): 78,167 @ $3.42 · Option exercise (M): 152,439 (derivative) @ $0 | EDGAR |
| 2025-02-25 | 4 | Simon Barry J. — Director | Option exercise (M): 15,243 @ $0 · Tax withholding (F): 5,453 @ $3.42 · Option exercise (M): 15,243 (derivative) @ $0 | EDGAR |
| 2025-02-25 | 4 | LAUER REGAN J — Chief Accounting Officer | Option exercise (M): 4,065 @ $0 · Tax withholding (F): 1,669 @ $3.42 · Option exercise (M): 4,065 (derivative) @ $0 | EDGAR |
| 2025-02-25 | 4 | SOON-SHIONG PATRICK — See remarks, Director, 10% owner CALIFORNIA CAPITAL EQUITY, LLC — 10% owner MP 13 Ventures, LLC — 10% owner Cambridge Equities, LP — 10% owner Nant Capital, LLC — 10% owner | Option exercise (M): 114,329 @ $0 · Tax withholding (F): 42,071 @ $3.42 · Option exercise (M): 114,329 (derivative) @ $0 | EDGAR |
| 2025-02-12 | 4 | Sachs David C. — Chief Financial Officer | Grant/award (A): 246,710 (derivative) @ $0 · Grant/award (A): 843,750 (derivative) @ $0 | EDGAR |
| 2025-02-12 | 4 | Adcock Richard — CEO & President, Director | Grant/award (A): 822,368 (derivative) @ $0 · Grant/award (A): 2,812,500 (derivative) @ $0 | EDGAR |
| 2025-02-12 | 4 | LAUER REGAN J — Chief Accounting Officer | Grant/award (A): 16,447 (derivative) @ $0 · Grant/award (A): 56,250 (derivative) @ $0 | EDGAR |
| 2025-02-12 | 4 | SOON-SHIONG PATRICK — See remarks, Director, 10% owner | Grant/award (A): 822,368 (derivative) @ $0 · Grant/award (A): 2,812,500 (derivative) @ $0 | EDGAR |
Recent 8-K events — ImmunityBio, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-04 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-30 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-10 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-18 | 8-K | 1.01 — Entry into a Material Definitive Agreement 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-07 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-09 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-06 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-31 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-23 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-18 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=IBRX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →